Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 3.Ident. | Authors (with country if any) | Title |
---|---|---|
000C19 | R. Bell [Australie] ; J. Brown [Royaume-Uni] ; M. Parmar [Royaume-Uni] ; M. Toi [Japon] ; T. Suter [Suisse] ; G G Steger [Autriche] ; X. Pivot [France] ; J. Mackey [Canada] ; C. Jackisch [Allemagne] ; R. Dent [Canada] ; P. Hall [Royaume-Uni] ; N. Xu [Suisse] ; L. Morales [Suisse] ; L. Provencher [Canada] ; R. Hegg [Brésil] ; L. Vanlemmens [France] ; A. Kirsch [Allemagne] ; A. Schneeweiss [Allemagne] ; N. Masuda [Japon] ; F. Overkamp [Allemagne] ; D. Cameron [Royaume-Uni] | Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer. |
007119 | A. Chan [Australie] ; D. W. Miles [Royaume-Uni] ; X. Pivot [France] | Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer |
008705 | X. Pivot [France] ; P. Koralewski [Pologne] ; J. L. Hidalgo [Argentine] ; A. Chan [Australie] ; A. Gonçalves [France] ; G. Schwartsmann [Brésil] ; S. Assadourian ; J. P. Lotz [France] | A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients |
This area was generated with Dilib version V0.6.33. |